Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Department of Neurology

Heinrich-Heine University

Moorenstrasse 5

40225 Duesseldorf

Germany

Name/email consistency: high

Department of Neurology, Heinrich-Heine University, Moorenstrasse 5, 40225 Duesseldorf, Germany. 2002 - 2009
Department of Neurology, Research Group for Clinical and Experimental Neuroimmunology, Heinrich-Heine-University, Düsseldorf, Germany. 2003

The future of multiple sclerosis therapy. Kieseier, B.C., Wiendl, H., Hartung, H.P., Stüve, O. Pharmacol. Res. (2009) [Pubmed]
Immunomodulatory treatment strategies in multiple sclerosis. Kieseier, B.C., Wiendl, H., Leussink, V.I., Stüve, O. J. Neurol. (2008) [Pubmed]
Intravenous immunoglobulins in the treatment of immune neuropathies. Kieseier, B.C., Meyer Zu Hörste, G., Lehmann, H.C., Gold, R., Hartung, H.P. Curr. Opin. Neurol. (2008) [Pubmed]
Oral disease-modifying treatments for multiple sclerosis: the story so far. Kieseier, B.C., Wiendl, H. CNS. Drugs (2007) [Pubmed]
Multiple sclerosis: advances, excitements, disenchantments. Kieseier, B.C., Wiendl, H. Lancet. Neurol (2006) [Pubmed]
Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases. Kieseier, B.C., Archelos, J.J., Hartung, H.P. Arch. Neurol. (2004) [Pubmed]
ADAM-10 and ADAM-17 in the inflamed human CNS. Kieseier, B.C., Pischel, H., Neuen-Jacob, E., Tourtellotte, W.W., Hartung, H.P. Glia (2003) [Pubmed]
Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Kieseier, B.C., Tani, M., Mahad, D., Oka, N., Ho, T., Woodroofe, N., Griffin, J.W., Toyka, K.V., Ransohoff, R.M., Hartung, H.P. Brain (2002) [Pubmed]